Media-OutReach Newswire SSY announces 2023 interim results Net profit HK$639 million; Interim dividend HK$0.07/share Determined to seize opportunities; Maintain stable & healthy development
Media-OutReach Newswire Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases
Media-OutReach Newswire Coface Asia Corporate Payment Survey 2023: Asian companies experience fewer payment delays and are rather optimistic despite multiple headwinds ahead